Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 4:32 pm Sale | 2025-09-30 | 13G | LENZ Therapeutics, Inc. LENZ | Paradigm BioCapital Advisors LP | 1,073,461 3.800% | -346,371![]() (-24.40%) | Filing History |
| 2025-11-14 4:03 pm Sale | 2025-09-30 | 13G | LENZ Therapeutics, Inc. LENZ | Point72 Asset Management, L.P. | 1,357,751 4.800% | -524,942![]() (-27.88%) | Filing History |
| 2025-11-10 4:48 pm Sale | 2025-11-05 | 13D | LENZ Therapeutics, Inc. LENZ | Versant Venture Capital VI, L.P. | 1,050,599 3.400% | -132,944![]() (-11.23%) | Filing History |
| 2025-11-07 4:47 pm Purchase | 2025-11-05 | 13D | LENZ Therapeutics, Inc. LENZ | RA Capital Management, L.P. | 4,265,106 13.600% | 4,500![]() (+0.11%) | Filing History |
| 2025-11-07 11:13 am Purchase | 2025-10-31 | 13G | LENZ Therapeutics, Inc. LENZ | FMR LLC | 4,278,244 15.000% | 4,278,244![]() (New Position) | Filing History |
| 2025-10-17 6:13 pm Purchase | 2025-09-30 | 13G | LENZ Therapeutics, Inc. LENZ | BlackRock Inc. BLK | 1,442,864 5.100% | 1,442,864![]() (New Position) | Filing History |
| 2025-09-22 4:20 pm Sale | 2025-09-18 | 13D | LENZ Therapeutics, Inc. LENZ | Versant Venture Capital VI, L.P. | 1,183,543 4.100% | -216,677![]() (-15.47%) | Filing History |
| 2025-08-20 5:13 pm Sale | 2025-08-18 | 13D | LENZ Therapeutics, Inc. LENZ | Versant Venture Capital VI, L.P. | 1,400,220 4.900% | -175,679![]() (-11.15%) | Filing History |
| 2025-07-14 4:50 pm Sale | 2025-07-10 | 13D | LENZ Therapeutics, Inc. LENZ | Versant Venture Capital VI, L.P. | 1,575,899 5.600% | -391,376![]() (-19.89%) | Filing History |
| 2025-06-24 4:21 pm Sale | 2025-06-20 | 13D | LENZ Therapeutics, Inc. LENZ | Versant Venture Capital VI, L.P. | 1,967,275 7.000% | -133,924![]() (-6.37%) | Filing History |
| 2025-06-12 4:49 pm Unchanged | 2025-06-10 | 13D | LENZ Therapeutics, Inc. LENZ | Versant Venture Capital VI, L.P. | 2,101,199 7.500% | 0 (Unchanged) | Filing History |
| 2025-05-09 4:19 pm Purchase | 2025-05-07 | 13D | LENZ Therapeutics, Inc. LENZ | RA Capital Management, L.P. | 4,260,606 15.100% | 4,260,606![]() (New Position) | Filing History |
| 2025-03-27 4:21 pm Purchase | 2025-03-20 | 13G | LENZ Therapeutics, Inc. LENZ | Paradigm BioCapital Advisors LP | 1,419,832 5.200% | 1,419,832![]() (New Position) | Filing History |
| 2024-11-14 4:00 pm Purchase | 2024-09-30 | 13G | LENZ Therapeutics, Inc. LENZ | TANG CAPITAL MANAGEMENT, LLC | 766,940 2.800% | 766,940![]() (New Position) | Filing History |
| 2024-11-08 5:08 pm Unchanged | 2024-08-14 | 13D | LENZ Therapeutics, Inc. LENZ | Versant Venture Capital VI, L.P. | 2,101,199 7.600% | 0 (Unchanged) | Filing History |
| 2024-07-29 4:12 pm Purchase | 2024-07-17 | 13G | LENZ Therapeutics, Inc. LENZ | Ridgeback Capital Investments L.P. | 1,951,875 7.200% | 1,951,875![]() (New Position) | Filing History |
| 2024-04-08 2:46 pm Purchase | 2024-03-21 | 13G | LENZ Therapeutics, Inc. LENZ | EcoR1 Capital, LLC | 1,219,774 4.800% | 1,219,774![]() (New Position) | Filing History |
| 2024-03-28 4:30 pm Purchase | 2024-03-21 | 13G | LENZ Therapeutics, Inc. LENZ | Alpha Wave Ventures GP Ltd | 3,612,211 14.100% | 3,612,211![]() (New Position) | Filing History |
| 2024-03-28 4:16 pm Purchase | 2024-03-21 | 13D | LENZ Therapeutics, Inc. LENZ | RA Capital Management, L.P. | 4,250,856 16.600% | 4,250,856![]() (New Position) | Filing History |
| 2024-03-25 8:42 pm Purchase | 2024-03-21 | 13G | LENZ Therapeutics, Inc. LENZ | Samsara BioCapital, L.P. | 1,213,865 4.800% | 1,213,865![]() (New Position) | Filing History |

